TSHA
NASDAQStockTaysha Gene Therapies, Inc.
$4.50-0.10 (-2.28%)
52-Week Range
$1.13
$5.91
Key Stats
Market Cap
1.2B
P/E Ratio
—
Dividend Yield
—
Beta
1.08
Volume
3.3M
Avg Volume
2.5M
Performance
1M
-0.86%
3M
-19.97%
6M
+52.65%
YTD
-12.19%
1Y
+168.02%
3Y
+424.88%
5Y
-82.56%
Price Chart
ETF Exposure
TSHA is held by 92 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| PTH | Invesco Dorsey Wright Healthcare Momentum ETF | 1.36% |
| IBRN | iShares Neuroscience and Healthcare ETF | 1.35% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.84% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.62% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 0.37% |
| CURE.AX | Global X - S&P Biotech ETF | 0.35% |
| DWAS | Invesco Dorsey Wright SmallCap Momentum ETF | 0.35% |
| XBI | State Street SPDR S&P Biotech ETF | 0.35% |
| IWC | iShares Micro-Cap ETF | 0.21% |
| PQSG | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF | 0.20% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.15% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.14% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.11% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.09% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.09% |
| IBB | iShares Biotechnology ETF | 0.09% |
| VMO.TO | Vanguard Global Momentum Factor ETF | 0.08% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.07% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.07% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.07% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.07% |
| GINN | Goldman Sachs Innovate Equity ETF | 0.07% |
| IWO | iShares Russell 2000 Growth ETF | 0.07% |
| PWS | Pacer WealthShield ETF | 0.07% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.06% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.06% |
| RSSL | Global X - Russell 2000 ETF | 0.04% |
| IWM | iShares Russell 2000 ETF | 0.03% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.03% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.03% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.03% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.03% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.03% |
| VTWO | Vanguard Russell 2000 ETF | 0.03% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.03% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.03% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.03% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.03% |
| UWM | ProShares - Ultra Russell2000 | 0.02% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.02% |
| TEXN | iShares Texas Equity ETF | 0.02% |
| URTY | ProShares - UltraPro Russell2000 | 0.02% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| VHT | Vanguard Health Care ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| IUSN.DE | iShares MSCI World Small Cap UCITS ETF | 0.01% |
Page 1 of 2Next
About TSHA ETF Exposure
Taysha Gene Therapies, Inc. (TSHA) is held by 92 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.2B, TSHA is a widely held institutional stock. The stock currently trades at $4.50. Investors can gain exposure to TSHA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TSHA, sorted by portfolio weight.